Julia Stegherr

发表

Impact of proton pump inhibitors on the antiplatelet effects of clopidogrel

M. Hadamitzky, A. Kastrati, A. Schömig, 2009, Thrombosis and Haemostasis.

Cytochrome P450 2C19 loss-of-function polymorphism and stent thrombosis following percutaneous coronary intervention.

A. Kastrati, J. Mehilli, A. Schömig, 2008, European heart journal.

A double-blind, randomized study on prevention and existence of a rebound phenomenon of platelets after cessation of clopidogrel treatment.

A. Kastrati, J. Mehilli, M. Seyfarth, 2010, Journal of the American College of Cardiology.

Cytochrome 2C19*17 Allelic Variant, Platelet Aggregation, Bleeding Events, and Stent Thrombosis in Clopidogrel-Treated Patients With Coronary Stent Placement

A. Kastrati, A. Schömig, T. Schuster, 2010, Circulation.

Antiplatelet effects of clopidogrel and bleeding in patients undergoing coronary stent placement

A. Kastrati, J. Mehilli, A. Schömig, 2010, Journal of thrombosis and haemostasis : JTH.

Clopidogrel response status assessed with Multiplate point-of-care analysis and the incidence and timing of stent thrombosis over six months following coronary stenting

A. Kastrati, J. Mehilli, A. Schömig, 2009, Thrombosis and Haemostasis.

Association between inflammatory biomarkers and platelet aggregation in patients under chronic clopidogrel treatment

S. Steinhubl, A. Kastrati, J. Mehilli, 2010, Thrombosis and Haemostasis.

Isolated and interactive impact of common CYP2C19 genetic variants on the antiplatelet effect of chronic clopidogrel therapy

A. Kastrati, J. Mehilli, A. Schömig, 2010, Journal of thrombosis and haemostasis : JTH.

Oral anticoagulation with coumarin derivatives and antiplatelet effects of clopidogrel.

A. Kastrati, J. Mehilli, A. Schömig, 2010, European heart journal.

Stability of the high on-treatment platelet reactivity phenotype over time in clopidogrel-treated patients

A. Kastrati, A. Schömig, D. Sibbing, 2010, Thrombosis and Haemostasis.